Madrigal Pharmaceuticals (FRA:YDO1) Operating Cash Flow per Share

: €-16.13 (TTM As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

Madrigal Pharmaceuticals's operating cash flow per share for the three months ended in Dec. 2023 was €-3.71. Madrigal Pharmaceuticals's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was €-16.13.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -19.40% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -59.60% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 5.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Madrigal Pharmaceuticals's Operating Cash Flow per Share or its related term are showing as below:

FRA:YDO1' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -86.2 Med: 5.5 Max: 59.8
Current: -19.4

During the past 13 years, Madrigal Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 59.80% per year. The lowest was -86.20% per year. And the median was 5.50% per year.

FRA:YDO1's 3-Year OCF Growth Rate is ranked worse than
73.87% of 1236 companies
in the Biotechnology industry
Industry Median: 3.5 vs FRA:YDO1: -19.40

Madrigal Pharmaceuticals Operating Cash Flow per Share Historical Data

The historical data trend for Madrigal Pharmaceuticals's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Madrigal Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

-2.43

-8.38

-9.84

-12.39

-15.91

Madrigal Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Operating Cash Flow per Share																-3.20	-4.32	-3.80	-4.31	-3.71

Competitive Comparison

For the Biotechnology subindustry, Madrigal Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Madrigal Pharmaceuticals Price-to-Operating-Cash-Flow Distribution

For the Biotechnology industry and Healthcare sector, Madrigal Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Madrigal Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.

Madrigal Pharmaceuticals Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Madrigal Pharmaceuticals's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-297.319	/	18.688
	=	-15.91

Madrigal Pharmaceuticals's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-73.299	/	19.773
	=	-3.71

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-16.13

Madrigal Pharmaceuticals Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Madrigal Pharmaceuticals's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Madrigal Pharmaceuticals (FRA:YDO1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Madrigal Pharmaceuticals Inc (FRA:YDO1) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

MDGL:USA

Address

200 Barr Harbor Drive, Suite 200, Four Tower Bridge, West Conshohocken, PA, USA, 19428

Website

http://www.madrigalpharma.com

Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.

Madrigal Pharmaceuticals (FRA:YDO1) Headlines

No Headlines